Bausch Health Companies Inc expected to post earnings of 88 cents a share - Earnings Preview

Bausch Health Companies

30/07/2024 19:04

* Bausch Health Companies Inc  BHC.TO   is expected to show
a rise
in quarterly revenue when it reports  results on August 1 for
the period ending June 30 2024
    * The Laval Quebec-based  company is expected to report a
8.0% increase in revenue to $2.34 billion from $2.17 billion a
year ago, according to the mean estimate from 5 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Bausch Health Companies
Inc is
for earnings of 88 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bausch
Health
Companies Inc is $9.75​, above​ its last closing price
of C$8.24. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001               0.72       0.60      Missed  -16.4
 Dec. 31 0001              1.00       1.15      Beat    14.5
 Jan. 1 0001   0.92        0.90       1.02      Beat    13.9​
 Jun. 30 2023  0.76        0.76       0.82      Beat    7.6
 ​​Mar.        0.73        0.72       0.52      Missed  -27.6
 31 2023                                                
 Dec. 31 2022  0.92        0.91       1.03      Beat    13.7​
 Jan. 1 0001   0.84        0.87       0.76      Missed  -12.6
 Jan. 1 0001   0.89        0.89       0.56      Missed  -37.3
 This summary was machine generated July 30 at 18:04 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)